Clinical studies recruiting near Kiel

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Universitaetsklinikum Schleswig-Holstein AöR · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Universitaetsklinikum Schleswig-Holstein Campus Kiel · Bristol-Myers Squibb · NCT07106762 Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
Phase N/A · Department of Dermatology, University Hospital Schleswig Hol · University Hospital Schleswig-Holstein · NCT03361215 Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due
NA · Universitätsklinikum Schleswig-Holstein · iVascular S.L.U. · NCT07357285 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 LEOPARD Prospective Validation Cohort 1
Phase N/A · Universitätsklinikum Schleswig - Holstein | UKSH · Transplan · Assistance Publique - Hôpitaux de Paris · NCT06723275 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · UNIVERSITAETSKLINIKUM SCHLESWIG-HOLSTEIN - Med. Klinik II - · The Lymphoma Academic Research Organisation · NCT06006117 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Schmerzklinik Kiel GmbH, Merz Investigational Site #0490395 · Merz Therapeutics GmbH · NCT07018700 Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)
NA · Saphir Radiosurgery Center Norther Germany · University Hospital Schleswig-Holstein · NCT06914544 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Universitatsklinikum Schleswig Holstein Kiel · Janssen Research & Development, LLC · NCT07499232 A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cance
Phase 3 · University Hospital Schleswig-Holstein (AöR) · OncoZenge AB · NCT07672236 Ablation of Consecutive Atrial Tachycardia
NA · Universitätsklinikum Schleswig Holstein · Evangelical Hospital Düsseldorf · NCT05239364 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Stadtisches Krankenhaus Kiel · Regeneron Pharmaceuticals · NCT06091865 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 2760004 · Sanofi · NCT06958536 TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis
Phase N/A · Head Centre for Inflammatory Skin Diseases, Department of De · Technische Universität Dresden · NCT03057860 International HIT-MED Registry (I-HIT-MED)
Phase N/A · UK-SH Campus Kiel · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Universitätsklinikum Schleswig-Holstein - Campus Kiel · Longboard Pharmaceuticals · NCT06660394 Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Phase 1/Phase 2 · Universitätsklinikum Schleswig-Holstein · Heidelberg Pharma AG · NCT04879043 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Universitaetsklinikum Schleswig-Holstein Campus Kiel · Celgene · NCT05519085 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Gastroenterologisch - Hepatologisches MVZ Kiel GmbH · Gilead Sciences · NCT06051617 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Städtisches Krankenhaus Kiel · Goethe University · NCT02872987 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · Universitatsklinikum Schleswig-Holstein · AgNovos Healthcare, LLC · NCT04796350 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Universitätsklinikum Schleswig-Holstein, Campus Kiel · Boehringer Ingelheim · NCT06531824 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Universitaetsklinikum Schleswig-Holstein - Kiel · Amgen · NCT07005128 REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Phase 3 · Regeneron Pharmaceuticals · NCT07410117 Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosi
Phase 3 · Universitätsklinikum Schleswig-Holstein - Campus Kiel · Takeda · NCT05677971 Post-Market Clinical Follow Up Study With Navitor Valve
Phase N/A · Universitätsklinikum Schleswig-Holstein - Campus Kiel · Abbott Medical Devices · NCT06008080 Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Phase 2 · Universitätsklinikum Schleswig-Holstein · Technische Universität Dresden · NCT05904106 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0072 · Bristol-Myers Squibb · NCT03899155 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738

Look up another city

Look up another condition